Mr. James Parsons

Chief Financial Officer

Mr. Parsons has an extensive background in the life sciences industry and over 25 years of financial management experience. Mr. Parsons has significant experience in financing, contract negotiation, risk management, corporate governance and public company reporting. His past involvement in biotechnology includes roles with Amorfix Life Sciences Ltd., DiaMedica Inc., Trillium Therapeutics Inc. and YM BioSciences Inc. Mr. Parsons serves on the boards of Sernova Corp and DiaMedica Therapeutics where he chairs the audit committees. He has a Master of Accounting degree from the University of Waterloo and is a Chartered Professional Accountant and Chartered Accountant.